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Abstract 
Each year in the United States, at least 2 million people become infected with 
bacteria that are resistant to antibiotics. Approximately 23,000 people die each year as a 
direct result of these infections, which makes antibiotic resistance an important topic of 
research. The Gerczei lab is investigating a mechanism of antibiotic resistance that involves 
the ykkCD riboswitch. This riboswitch was first discovered in Bacilis subtilis, and it 
specifically recognizes the tetracycline family of antibiotics. When tetracycline is present in 
the cell, the antibiotic induces synthesis of the riboswitch mRNA which leads to the 
production of an efflux pump. This pump serves as a transporter protein and pumps the 
antibiotic out of the cell, rendering the cell resistant to tetracycline. The objective of this 
project is to detect structural changes occurring within the secondary structure of the 
ykkCD riboswitch RNA in response to tetracycline binding using nucleic acid footprinting 
methods. Ultimately, the hope is to use these footprinting techniques to determine the 
binding site of tetracycline on the RNA and map the structural change caused by 
tetracycline binding. 
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Process Analysis Statement 
I completed an independent research project under the advisory of Dr. Timea 
Gerczei to study how the binding of the antibiotic tetracycline affects the secondary 
structure of the ykkCD RNA. Antibiotic resistance is an ever-growing problem, and 
tetracycline is known to induce a resistance mechanism within bacterial cells that contain 
ykkCD RNA. When tetracycline enters the cell it binds to the RNA, which induces a 
structural change in the RNA that allows transcription to continue. As a result, a multi-drug 
resistance efflux pump is produced that pumps the antibiotic out of the cell. Therefore, the 
structural change that occurs within the RNA to allow for pump production is of interest 
since it results in resistant bacterial cells. 
This research project was both challenging and exciting for me. I was able to utilize 
many of the laboratory techniques that I previously learned in the classroom, and I was 
exposed to new techniques that are commonly used in professional biochemistry 
laboratories. I enjoyed being able to directly apply my education in an independent setting. 
The project was not without challenges. As with much scientific research, it took a large 
amount of time and repetition to collect results. It was difficult to not be discouraged when 
long hours of meticulous work would produce little to no data. However, I was able to 
improve as a researcher and appreciate small victories. 
The project served as a valuable extension of my education, and it will also be useful 
for future researchers in the chemistry department at Ball State University. I hope that 
future students will be able to use this data to further research the secondary structure of 
ykkCD RNA. Studies regarding antibiotic resistance will continue to be an important area of 
research in the future, and I am proud to have participated in a small part of it. 
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Introduction 
Discovery of Antibiotics 
The age of antibiotics began in 1928 when Alexander Fleming, Professor of 
Bacteriology at St. Mary's Hospital in London, discovered penicillin. Antibiotics are 
produced by fungi or bacteria and have the ability to inhibit or kill other microbial species. 
Fleming was studying colonies of Staphylococcus au reus in petri dishes when he noticed 
that there was an area of inhibited growth surrounding a mold. This mold, later identified 
as Penicillium nota tum, secreted a substance that was capable of killing different harmful 
bacteria, including streptococcus and meningococcus.l 
Following Fleming's work, more research was conducted at Oxford University to 
further the fermentation and purification techniques used for penicillin production. In 
1941, Albert Alexander was the first patient to receive penicillin. Research then moved to 
the United States in 1941 and several pharmaceutical companies, including Lilly and Pfizer, 
began to mass-produce penicillin after developing more efficient growth and fermentation 
methods.1 Penicillin quickly became a key component of the war effort during that time, 
used to treat many soldiers with bacterial infections -during World War II. Therefore, large-
scale production of penicillin incited the age of antibiotics and a revolution within the 
pharmaceutical industry. Other antibiotics began to be discovered and developed, 
including tetracycline, erythromycin, and methicillin. However, at the very beginning of the 
antibiotic age, Fleming warned that "the public will demand [the drug and] ... then will begin 
an era ... of abuses," which he proposed would lead to eventual bacterial resistance.15 
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History of Antibiotic Resistance 
Just as Fleming cautioned years earlier, bacteria adapted and became resistant to 
penicillin by the 1950s. Since then many other antibiotics have been discovered, only to 
later be counteracted by antibiotic-specific bacterial resistance. Unfortunately, resistant 
strains of bacteria have been identified for the majority of antibiotics that have been 
developed since the 1940s. There are several potential causes behind the emergence of 
resistant strains of bacteria. One of the main causes is simply overuse. Studies have shown 
that there is a direct correlation between consumption of antibiotics and the development 
of bacterial resistance. Because antibiotics are produced by bacteria themselves, these 
bacteria are inherently capable of mutating and adapting in order to survive. When 
antibiotics are consumed any drug-sensitive bacteria are killed and resistant bacteria are 
left behind to grow and reproduce. Therefore, overuse of antibiotics leads to increased 
presence of resistant bacteria.1s 
Another cause of overuse is inappropriate prescribing by primary physicians and 
hospitals. Studies done previously indicate that treatment indication, choice of antibiotic, 
or duration of therapy is wrong in 30-50% of cases. Another study suggested that 30-60% 
of antibiotics prescribed in intensive care units are unnecessary or inappropriate. When 
antibiotics are prescribed incorrectly, they are more detrimental than beneficial and can 
promote resistance by inducing mutagenesis and altered gene expression. Additionally, 
resistant bacteria can be passed to humans through food consumption, specifically meat 
products. Antibiotics are commonly given to livestock as growth supplements to prevent 
infection and promote growth. While this method can lead to higher quality products, it 
also contributes to the growing antibiotic resistance crisis. When livestock are given 
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antibiotics only the resistant bacteria survive and they can then be transmitted to the 
humans who consume those food products.l5 
Lastly, the lack of availability of new antibiotics plays a role in the current crisis. 
When antibiotics were first discovered researchers were able to discover and develop new 
drugs when resistance to a previous antibiotic would be discovered. Now, however, new 
antibiotics are not being identified as readily due to economic and regulatory obstacles. 
For several pharmaceutical companies antibiotic research is not a solid investment since 
these drugs are used for such a short period of time and are often remedial, which makes 
them not as profitable. Similarly, different regulatory changes made by the FDA over the 
past few decades have made clinical studies much more expensive for pharmaceutical 
companies. Therefore, fewer companies are conducting research and fewer antibiotics are 
being discovered, which makes it more difficult to counter the ongoing battle against 
resistant bacteria.1s 
Mechanisms of Antibiotic Resistance 
In order to fight against antibiotics, bacteria employ two main methods to adapt to 
their respective antibiotic: mutations in genes or attainment of external genetic material 
that is already resistant. Bacteria can obtain resistant foreign DNA by three different 
methods: transformation, conjugation, and transduction (Figure 1). Transformation 
involves the incorporation offree exogenous DNA into a recipient cell. Conjugation is the 
transfer of genetic material via cell-to-cell contact. Plasmids containing the resistant gene 
are passed from one cell into the recipient cell. During transduction, the resistant gene is 
introduced into the cell via viral delivery.z 
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Transduction Transformation Conjugation 
Figure 1. Schematic of the three methods involved in horizontal gene transfer of resistant 
genes into bacteria.13 
Once a bacterial cell becomes resistant due to a mutation or one of the above 
methods of gene transfer, there are several mechanisms that are employed to counteract 
the presence of antibiotics (Figure 2). The first resistance mechanism is the chemical 
alteration or destruction of the antibiotic molecule. In this case, the bacteria cell produces 
enzymes that are able to alter the molecule through acetylation, phosphorylation, and 
adenylation. The addition of these different chemical moieties results in a decreased level 
of avidity for the antibiotic and its intended target. Similarly, the cell can also produce 
enzymes to break down the antibiotic so that it is never able to reach its target. The second 
resistance mechanism involves the decreased permeability of the cell membrane and 
therefore decreased uptake of the antibiotic molecules. The third resistance mechanism 
works by protecting the target site by bypassing it altogether. The cell is able to produce an 
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alternative enzyme that can be used instead of the protein that is inhibited by the antibiotic. 
Therefore, the antibiotic binds to the alternate protein and isn't able to bind to its intended 
protein so the cell survives. Similarly, the cell can induce modifications of the target site, 
which results in decreased affinity of the antibiotic for its target. Lastly, a cell can resist the 
effects of antibiotics by pumping the antibiotic out of the bacterial cell through transporter 
proteins known as efflux pumps.lO 
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Figure 2. Model of the antibiotic resistance mechanisms mentioned above.12 
Efflux Pumps 
An efflux pump system that extruded tetracycline from bacterial cells was one of the 
first to be described in the early 1980s.10 Efflux pumps are transport proteins that expel 
toxic substances from inside the cell to the external environment. In this case, bacterial 
cells are able to pump out antibiotics that threaten the survival and growth of the cell. 
These pumps can be specific to one antibiotic or they can transport a range of different 
compounds, which contributes to the threat of multiple drug resistance. There are five 
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major families of these transporter proteins, and the majority of them use proton motive 
force as the energy source behind the expulsion of toxic substances.4 
These efflux pump proteins have been found to be encoded in both antibiotic 
susceptible and resistant bacteria. In non-resistant bacteria, efflux pumps are often part of 
an operon and have tightly regulated gene expression. However, in resistant bacteria 
overexpression of efflux pumps is associated with resistance. Genes encoding these 
proteins can be found on chromosomes or plasmids; however, when located on the 
chromosome the bacterium has an intrinsic mechanism to fight against antibiotics instead 
of requiring horizontal gene transfer.16 This intrinsic mechanism becomes activated when 
the bacterium detects the antibiotic molecule in its environment via ligand binding by 
transcription factors or riboswitches. 
Riboswitches 
A riboswitch is defined as a metabolite-binding domain within the messenger RNA 
that influences gene expression in response to ligand binding. These regulatory domains 
are highly conserved across prokaryotes and are found within the 5' untranslated region of 
the bacterial mRNA transcript. 17 A riboswitch is composed of two domains: the aptamer 
domain and the expression platform. The specific metabolite binds to the aptamer domain 
when the metabolite concentration reaches its threshold, which induces a conformational 
change within the expression platform. This structural change leads to modified expression 
of genes carried by the mRNAP 
In the majority of cases, metabolite binding to the riboswitch results in decreased 
expression of the gene due to transcription termination or translation inhibition. When the 
metabolite binds, the structural change results in the formation of a terminator hairpin that 
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destabilizes the complexes needed for elongation, which leads to attenuation. However, 
some riboswitches upregulate gene expression in response to metabolite bindingP In this 
case, the conformational change seen in Figure 3 occurs within the riboswitch mRNA. 
Terminator 
Metabolite 
5' uuvuvvu~~ 
Anmerminator 
Figure 3. Schematic respresenation of up regulation of gene expression in response to 
metabolite binding to riboswitch mRNA. 
As seen in Figure 3A, when the metabolite is not present in the cellular environment, the 
terminator stem is intact. The mRNA is released at that point and there is no expression of 
the gene directly downstream. In Figure 38, the metabolite is now present and binds to the 
aptamer domain of the riboswitch, which leads to a conformational change that unfolds the 
terminator stem and produces an antiterminator. Transcription is allowed to continue and 
expression of the downstream gene is upregulated.3 
There are currently 12 different classes of riboswitches discovered, but this 
research project focuses specifically on the ykkCD toxin sensor RNA, which is a riboswitch 
that recognizes tetracycline. This riboswitch was first discovered in Bacillus subti/is. The 
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ykkCD riboswitch is a highly conserved portion of mRNA that regulates the expression of 
the ykkCD multidrug resistant efflux pump (MDR pump). As explained above, an MDR 
pump is able to expel a variety of toxic substances out of a cell, more specifically antibiotics 
that threaten cell survival. When the pump is expressed in a bacterium, the antibiotic is 
removed from the cell thus rendered ineffective. The ykkCD riboswitch mRNA is found 
upstream ofthe gene that encodes for the ykkCD MDR efflux pump. As seen in Figure 4, 
when tetracycline is not present, the ykkCD riboswitch remains in the "off' position with 
the terminator stem intact so the gene. encoding the pump is not expressed. When 
tetracycline is introduced into the cell and reaches its threshold, it can bind to the aptamer 
domain ofthe riboswitch, which is found 5' to the expression platform. This leads to the 
unfolding of the terminator stem, which allows expression of the downstream gene. The 
pump protein is then produced and can actively expel tetracycline from the ceJJ.6 
Figure 4. Proposed secondary structure of the ykkCD riboswitch a pta mer predicted by mfold, 
a computational molecular biology program. 
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As seen in Figure 4, the ykkCD riboswitch contains the anticipated aptamer domain on the 
left and the expression platform on the right. 
Tetracycline Family Antibiotics 
As stated previously, the specific target of the ykkCD riboswitch is tetracycline 
(Figure 5). This antibiotic is used to treat bacterial infections, such as pneumonia and other 
respiratory infections as well as acne and other skin infections.14 Tetracyclines were 
discovered in the 1940s and fight bacteria by inhibiting protein synthesis. These 
antibiotics are relatively inexpensive, which has led to a high rate of prescription and 
therefore resistance.s 
HO 
NH2 
OH 0 
Figure 5. Chemical structure of tetracycline. 
In order to determine whether the ykkCD riboswitch specifically binds tetracycline to 
induce production of the efflux pump, previousresearch was done to analyze ykkCD efflux 
pump levels in the presence of a variety of ligands. Tetracycline, streptomycine, 
chloramphenicol, TPPC, and fosfomycin are ligands of the ykkCD efflux pump; therefore, all 
of these ligands were tested to see whether they triggered expression of the pump. When B. 
subtilis cells were grown in the presence of each of these substances, the following 
information in Figure 6 was collected.6 
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Figure 6. Fgiure of mRNA levels of the ykkCD pump in response to a variety of antibiotics. 
Adapted from Caronline Conley's research.6 
As seen in Figure 6, the level ofykkCD pump mRNA was highest in the presence of 
tetracycline, which supports the hypothesis that tetracycline specifically binds to induce 
expression of the ykkCD efflux pump. 
Similarly, previous research was done by Delores James using binding assays with 
four derivatives of tetracycline to determine which tetracycline functional groups are 
essential for recognition. The four derivatives studied were minocycline, 
anhydrotetracycline, oxytetracycline, and doxycycline. Tetracycline and these derivatives 
are naturally fluorescent, so once the antibiotic binds to the sensor it undergoes quenching 
and the fluorescence decreases. According to these binding assays, it was found that 
minocycline and anhydrotetracycline bind to the riboswitch in addition to tetracycline.8 
However, oxytetracycline and doxycycline did not bind. As seen in Figure 7, both 
minocycline and anhydrotetracycline alter the lower face of tetracycline, which suggests 
that the lower side is not as important to recognition since these two derivatives both still 
bind the riboswitch. On the other hand, both oxytetracycline and doxycycline alter the 
upper side of the antibiotic, which suggests that this upper area of tetracycline affects the 
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ability for recognition since these two derivatives did not bind.8 In order to continue 
studying the binding of tetracycline to the ykkCD riboswitch mRNA, several probing 
techniques are used to analyze the conformational changes that occur in response to ligand 
binding. 
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Figure 7. Chemical structures of tetracycline and its derivatives used in a binding assay to 
study direct and specific binding of tetracycline to the ykkCD riboswitch. 
Structure Probing Techniques 
RNA footprinting is an enzymatic method of mapping RNA structure to monitor 
ligand binding and conformational changes.7 By subjecting the RNA of interest to 
ribonuclease digestion, the subsequent cleavage pattern can be determined and analyzed 
using a thin gel called a sequencing gel. The distinct cleavage bands that appear on the 
sequencing gel make up the "footprint." There are several probing techniques that can be 
used for RNA footprinting, but the one studied here is ribonuclease protection. 
A variety of different enzymes with different substrate specificities are used to study 
the digestion products with and without ligand bound. A comparison of the ykkCD RNA and 
-
the ykkCD RNA-tetracycline complex footprints will reveal where tetracycline binds to the 
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ykkCD RNA. The region of RNA where tetracycline binds will be protected from digestion 
by the bound ligand, resulting in the absence of distinct bands in those areas on the 
sequencing gel. In order to visualize these cleavage patterns, the RNA is subjected to 
reverse transcription using a labeled primer. The resulting end-labeled DNAs are resolved 
on a sequencing gel. An example of a sequencing gel that detects structural changes in the 
presence of RNase Vl can be seen in Figure 8. RNase Vl specifically cleaves double-
stranded RNA. When there is no tetracycline present, the terminator stem is intact and the 
enzyme cleaves the double-stranded RNA, which is illustrated on the left hand side of 
Figure 8. When tetracycline is present, the stem unfolds and the cleavage bands disappear 
since the DNA is no longer double-stranded. 
A B 
Figure 8. Schematic of DNA illustrating the structural change that takes place when the 
antibiotic is introduced into the environment. These changes can be detected on a sequencing 
gel by analyzing the changes in the cleavage patterns in conjunction with the knowledge of 
the cleaving specificity of each RNase enzyme. 
Ribonuclease protections assays are a sensitive and specific method used for the 
detection, mapping, and quantitation of specific nucleotides in an RNA sequence.11 There 
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are a variety of ribonucleases available, but those used in this research project are RNase 
T1, V1, and 1. Each of these cleave RNA after specific nucleotides and at specific sites. 
RNase T1 cleaves at the 3' end of single-stranded G nucleotides. As mentioned previously, 
RNase V1 cleaves base paired nucleotides. RNase 1 cleaves all RNA dinucleotide bonds, 
which produces a 5' hydroxyl and 2',3' cyclic monophosphate. In conjunction with these 
RNases, an OH ladder and a T1ladder are also essential in order to effectively analyze the 
cleavage pattern on a denaturing gel. The hydroxyl (OH) ladder cleaves after every 
nucleotide while the T1ladder cleaves after every G nucleotide. The combination of these 
two ladders provide a method of identifying which nucleotides are being protected or 
altered due to ligand binding. A sample sequencing gel image can be seen in Figure 9, 
which shows the cleavage pattern of a sample of a ribonuclease protection assay. 
= ,. ·=41 
Figure 9. Sample sequencing gel done by Dr. Timea Gerczei that shows the cleavage patterns 
of ribonuclease 1 and Vl versus an OH ladder and Tlladder. 
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Determining Tetracycline Binding Site Using RNase Protection 
I conducted an independent research project to investigate and analyze the 
tetracycline binding site on the ykkCD riboswitch. The purpose of the study is to subject the 
ykkCD RNA to ribonuclease protection assays both with and without tetracycline in order 
to determine how ligand binding affects the cleavage pattern of the RNA I chose to focus on 
RNase protection assays instead of other probing techniques because they are very 
sensitive to secondary structural changes than other techniques. These nucleases have 
specificity in their ability to cleave so the cleavage patterns should change in a 
synchronized manner if structural change occurs and they should change in the same way 
when tetracycline binding occurs. These are significant benefits because it is important to 
be able to determine how ligand binding affects the secondary structure of the RNA in 
order to determine how tetracycline binding leads to alteration of gene expression. 
The RNase protection assays are also relatively easy to optimize because they have a 
set pH and buffer conditions. Therefore, it only requires optimization of the amount of 
nuclease that is required to produce the most indicative cleavage pattern. The sites where 
tetracycline binds to the RNA will be protected from nuclease digestion, which results in 
the absence of a band or a less intense band on a denaturing gel. In this research project, 
the cleavage patterns will be visualized using reverse transcription with labeled primers. 
Another option would be to use radiolabeling with nucleotides containing 32p, This is 
common technique used for nucleic acid labeling, but the radiolabeled nucleotides are 
expensive and decay quickly. Therefore, it was not conducive to use this technique in an 
undergraduate lab where the radiolabeled RNA would not be able to be used immediately 
following synthesis. Therefore, the cleavage patterns will be visualized using reverse 
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transcription since it is more cost effective and conducive to the hours spent in the 
undergraduate lab. By analyzing these cleavage pattern on a sequencing gel in conjunction 
with an OH ladder and T1ladder, the nucleotides that are affected by tetracycline binding 
can be identified. 
Materials and Methods 
ykkCD Riboswitch RNA Synthesis 
To design the ykkCD RNA of interest, the DNA template was first amplified using 
PCR technology. The DNA template for the ykkCD RNA is as follows: 
TAATACGACTCACTATAGGCCTTCGGGCCAATGTAAAGTTTTCTAGGGTTCCGCATGTCAATTGA 
CATGGACTGGTCCGAGAGAAAACACATACGCGTAAATAGAAGCGCGTATGCACACGGAGGGAAA 
AAAGCCCGGGAGAGTCGATCCGGTTCGCCGGATCCAAATCGGGCTTCGGTCCGGTTC 
where the underlined portion of the template is the T7 polymerase promoter sequence. 
Following the instructions of the manufacturer, the following components were added in a 
l.SmL centrifuge tube to make the PCR master mix: 1 11L DNA template, 10 JlL 10 mM top 
primer, 10 JlL 10 mM bottom primer, 200 JlL Sx reaction buffer, 20 11L 10mM dNTP mix, 
739 JlL water, and 20 JlL Thermo Scientific PHIRE Hot Start II DNA Polymerase. This 
solution was then aliquoted into 10 O.SmL tubes, which were placed in the Eppendorf 
Authorized Thermal Cycler to undergo PCR amplification. The series of steps involved in 
PCR amplification are outlined in Table 1. 
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Table 1. Outline ·of PCR reaction steps using the PH IRE program on the Eppendorf Authorized 
Th I C I erma .yc er. 
Temperature(°C) Time (sec) Action 
Step 1 98 30 Begin amplification process 
Step 2 98 5 Separate the DNA strands 
Step 3 39 5 Anneal primers 
Step 4 72 15 Amplification 
Repeat steps 2-4 for a total of 35 times- yields a large amount of DNA 
Step 5 72 60 Final amplification 
Step 6 4 infinite Allows storing 
Once the amplification was complete, the PCR product was purified using the Qiagen 
PCR Cleanup Kit per suggestion of the manufacturer. The PCR products were transferred 
into a 10mL tube and SmL of PB buffer was added and mixed. Using two PCR cleanup 
columns, 700 IlL of product was transferred into each column and centrifuged for two 
minutes at low speed. The materials that flowed through the column were discarded. This 
step was repeated several times until all of the PCR product had been added to the cleanup 
column. Each column was then washed with 700 j..LL PE buffer, centrifuged as before, and 
the flow through material was discarded. The columns were centrifuged for 1 minute at 
maximum speed, which removes ethanol from the PE buffer. The subsequent flow through 
material was discarded. The DNA was then eluted from the column. The column was placed 
in a clean centrifuge tube and 50 j..LL of elution buffer were pi petted onto the middle of the 
column. After a wait period of 1 minute, the tube was centrifuged for 1 minute at maximum 
speed. The DNA concentration was determined using the Thermo Scientific Nanodrop 1000 
Spectrometer with a typical yield of approximately 200 ng/!lL 
The DNA quality was checked using agarose gel electrophoresis. From a 40x stock, a 
1x TAE buffer was made and 100 j..LL was added to an Erlenmeyer flask along with l.Og 
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agarose. The solutions was microwaved for 2 minutes until all agarose was dissolved. 
Ethidium bromide (10 ~L, 10mgjmL) was added to the flask and the gel solution was 
poured into the casting gel. Upon solidification, 700 ~L of lx TAE buffer was added and two 
samples were loaded side by side: 5 ~L of a 50 bp molecular weight marker with 2 ~L 
loading dye and 5 ~L of the DNA sample with 2 ~L loading dye. The gel was run for 20 
minutes at 100V. The gel was imaged using the Biorad Molecular Imager on the ethidium 
bromide setting. A solitary strong band around 200 bp is indicative of a high quality DNA 
sample. 
Following the production ofykkCD DNA, transcription was completed to yield the 
ykkCD RNA of interest. A 500 ~L transcription mix was made using the following 
components: 
• 50 ~L lOX reaction buffer 
• 10 ~L rNTP mix 
• 52 ~L DNA 
• 25 ~L DTT 
• 50 ~L T7 RNA Polymerase 
• 313 ~L MilliQ water 
This reaction mix was placed in a 37°C water bath for 2 hours for transcription to occur. 
The DNA template was then removed using 10 ~L ofRNase free DNase and allowed to 
incubate for another 30 minutes. The remaining white pellet was dissolved using 50 ~L 
0.5 M EDTA (pH - 8.0). 
The transcribed RNA was precipitated using phenol/chloroform extraction and 
ethanol precipitation in order to reduce RNA volume and remove buffer, enzyme and 
unincorporated nucleotides. For the extraction, 500 ~L phenol/chloroform mix was added 
to the RNA to remove the polymerase. After vortexing and centrifugation, the top layer was 
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transferred into a centrifuge tube and 500 !J.L of chloroform was added to remove the 
phenol. After vortexing and centrifugation, the top layer was transferred to a new tube and 
underwent ethanol precipitation, which includes the following additions to the tube: 
• 50 !J.L 3M NaOAc (pH - 3.5) 
• 500 11L isopropanol 
• 11J.L glycogen (20 mgjmL) 
The solution was incubated overnight at -20°C. Following the incubation period, the RNA 
was recovered from the solution using the following protocol: 
• Centrifuge sample at maximum speed at 4°C for 30 minutes 
• Remove supernatant and discard- RNA is at the bottom of the tube 
• Add 100 IlL ice-cold 75% ethanol, centrifuge for 5 minutes at 4°C and discard 
supernatant 
• Dry pellet in Labconco speed-vac for 5 minutes 
• Dissolve RNA in 100 !J.L RNase-free water 
The recovered RNA was purified using a denaturing urea PAGE gel in order to remove any 
contamination from the RNA including lower molecular weight degradation products. The 
components used for the gel solution, urea dye, and running buffer can be seen in Table 2. 
Table 2. Volumes and contents of the gel solution, urea dye, and running buffer used for gel 
uri rcation o the recovered RNA. 
Gel Solution 0.5X TBE Runnin Buffer 
3.6 urea 50 mL lOX TBE buffer 
0.5 mL lOx TBE buffer 100 !J.L SX TBE buffer Water to 1 L mark 
5 mL40% 10 !J.L bromophenol blue 
Water to 1 mL mark 
Once the gel was prepared, it was pre-ran for 30 minutes at 15 W to ensure that all free 
ions and unincorporated nucleotides were removed from the gel. The RNA sample was 
prepared by adding 100 !J.L 0.5X urea dye to 100 !J.L RNA, then boiled fo r 10 minutes at 
100°C and centrifuged. The sample was ran on the gel for 1 hour at 15 W. Upon completion 
22 
of the run, the gel was removed and the band corresponding to full-length RNA was 
identified using ultra-violet (UV) shadowing. The gel was placed on a phosphor screen that 
fluoresces in the UV range. RNA absorbs UV light so when a UV light source was applied to 
the gel the screen was shaded where the band appears. This band is then excised from the 
gel to be further extracted and precipitated. 
The RNA was eluted from the excised gel band in order to recover the purified RNA. 
It was crushed by pushing the gel through a syringe into a 2 mL centrifuge tube. Crush and 
soak solution (1 mL) was added to the tube, which removes RNA from the gel, followed by 
0.5 mL phenol/chloroform, which prevents RNA from degrading. The mixture was 
incubated for 2 hours at 37°C. Following incubation, the mixture was centrifuged at low 
speed and the top layer was transferred to a new tube for chloroform extraction and 
ethanol precipitation. Chloroform (500 11L) was added to remove any residual phenol, 
followed by vortexting for 1 minute and centrifugation for 2 minutes. The top layer 
containing the RNA was transferred to a new tube and 100 11L 3M NaOAc (pH ~ 3.5), 1~-tL 
glycogen (20 mgfmL), and 1 mL isopropanol was added. The solution was incubated 
overnight at -20°C. The RNA was then recovered using the same recovery protocol used 
earlier (pg. 20), and the RNA concentration was determined using the same nanodrop 
spectrophotometer as before. The typical RNA yield was approximately 460 ng/11L. 
The purity of the recovered RNA was checked on a denaturing PAGE. The 
components of the gel solution, urea dye, and running buffer are the same as in Table 2 for 
the previous gel purification step. The prepared gel was pre-ran for 30 minutes at 15 W 
and the sample was prepared using 5 11L recovered RNA and 5 11L urea dye. The sample was 
boiled for 5 minutes at 100°C and centrifuged before loading. The 10 11L sample was loa.ded 
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and ran for 30 minutes at 1S W. The gel was then transferred into a container with 100 mL 
O.SX TBE buffer and 10 !J.L EtBr. The gel was placed on a mutator for S-10 minutes then 
photographed with the Biorad Molecular Imager. 
RNase Protection Assays 
The probing technique used in this research project is RNase protection assays, 
specifically using RNase T1, RNase V1, and RNase 1, which all cleave at different sites on 
the RNA Samples were made with a) enzyme and RNA and b) enzyme and RNA-
tetracycline complex in order to analyze cleavage patterns with and without ligand bound. 
Before the protection assays were made, all RNA was refolded so that it would be in its 
native state. To refold the RNA, it was boiled at 100°C for 2 minutes, centrifuged, then 
placed on ice for ten minutes. All of the components needed for the RNase protection 
assays can be found in Table 3. The four types of samples made can be found in Table 4, 
which include samples without ligand bound, samples with ligand bound, the OH ladder, 
and the T1ladder. 
Table 3. Volumes and concentrations of individual components needed to produce the 
'b I 'th d 'th t 1· d b d II th 1 dd n onuc ease assays w1 an Wl au 1,qan oun , as we as e necessary a ers. 
SX Reaction Buffer 10 mM Tetracycline T1 Buffer OH Buffer 
100 IlL 1M TrisHCl SO mg tetracycline SO IlL 1M TrisHCl 1 !J.L 1 mM glycine 
(pH ~ 8) (pH ~ 8) (pH ~ 9.5) 
250 IlL 2M KCl 10 mL DMSO 5 !J.L O.OS% Triton 0.5 IlL 1M MgClz 
X-100 
S !J.L 1M MgClz 1 IJ.L soln into 1 mL Water to 1 mL mark Water to 1 mL mark 
water 
Water to 1 mL mark 
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Table 4. Volumes and concentrations of each solution that is added in each individual 
centrifuge tube. A master mix was typically prepared by multiplying each of these volumes by 
the total number of dilutions that would be made for each type of sample. 
RNA Samples RNA-Tetracycline Samples OH Ladder Tl Ladder 
2 IlL 5X rxn buffer 2 IlL 5X rxn buffer 1~-tL RNA 1~-tL RNA 
1~-tL RNA 1~-tL RNA 0.5 11-L tRNA 0.3 11-L tRNA 
5. 7 11-L water 0.3 11-L tRNA 3.5 1X Alkaline 3. 7 11-L T1 buffer 
Hydrolysis buffer 
0.3 11-L tRNA 1 11-L 10 mM tetracycline 
4.7 11-L water 
As seen in the schematic in Figure 9, the individual components found in Table 4 
were aliquoted into their respective centrifuge tubes. Three serial dilutions for each sample 
and ladder were done in order to optimize which enzyme concentration produced the 
clearest cleavage pattern on the sequencing gel. Aside from the OH ladder, the respective 
ribonuclease (1 11-L) was added to the first tube in each set of samples, and then a 1:10 
dilution was done each time by pi petting 1 IlL from the first tube into the second tube and 
then 1 11-L from the second tube to the third tube. The three enzymes used were RNase T1 
(Ambion, 1 UfmL), RNase V1 (Ambion, 0.1 U/mL), and RNase 1 (Ambion, 100 UfmL). Once 
the enzyme was introduced into the sample, the solution was incubated at room 
temperature for exactly 15 minutes. As seen in Figure 9, each addition/transfer was done 
30 seconds apart (top number) and then each reaction was quenched 30 seconds apart 
(bottom number) with a 15 minute incubation period in between the start and end of the 
reaction. To quench each of the ribonuclease samples, 12 11-L of the quench solution (Table 
5) was added to each tube. 
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Ribonuclease T1 
1 p.4T1 
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''' 25 10 24.5 9.5 23 9 
Ribonuclease T1 
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''' 20.5 20 19.5 5.5 5 4.5 
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Ribonuclease V 1 
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Heat at 9 5"'C for: 
' ' ' 2 min 5 min 10 min 
Figure 10. Schematic representation of the protocol used for the RNase protection assays. 
With exception of the OH ladder, the top number under each tube represents the starting time 
. in minutes for that reaction and the bottom number represents the time that the quench 
solution was added to stop the reaction. The OH ladder is made by heating each solution and 
adding the quench solution after the allotted amount of time. 
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To quench the T1ladder samples, 6.5 1..1-L of the quench solution (Table 5) was added to stop 
the reaction. The protocol for the OH ladder involved heating each sample at 95°C for a 
different amount of time to achieve the cleanest fragmentation pattern (Figure 10). The 
first tube was heated for 2 minutes, the second tube for 5 minutes, and the third tube for 15 
minutes. Each reaction was stopped after it's allotted time by adding 6.5 1..1-L of the quench 
solution (Table 5). 
Table 5. Volumes and concentrations of components used in the quench solutions for both 
I dd d I a ers an samp. es. 
· _Quench Solution for Samples Quench Solution for Ladders 
11..1-L 3M NaOAc (pH- 3.5) 0.5 1..1-L 3M NaOAc (pH- 3.5) 
10 1..1-L isopropanol 5 1..1-L isopropanol 
1 1..1-L glycogen 1 1..1-L glycogen 
Immediately following the quench, every sample was placed in dry icefEtOH for 30 
minutes or incubated overnight at -20°C. Following incubation, each sample was 
centrifuged for 30 minutes at maximum speed followed by ethanol precipitation as before. 
Each pellet was dried in the speed vac for 5 minutes, and then used for reverse 
transcription. 
Reverse Transcription 
The reverse transcription protocol consisted of two steps: primer annealing and 
reverse transcription. The volumes and components of each of the solutions used in the 
reverse transcription protocol are found in Table 6. To anneal the primers, the RNA pellet 
of each sample was resuspended in 111..1-L water and transferred into a PCR tube. Primer 
solution (2 1..1-L of 3 11M stock) was added to each tube, which were then placed into the PCR 
machine and began the 1RTS program. Another PCR tube was added that included only 1 
!J.L clean RNA and 10 1..1-L water. The RTS program follows a 70 minute process: 
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• Primer annealing for a total of 10 minutes 
o 5 minutes at 65°C 
o 3 minutes at 45°C 
o 2 minutes at 4°( 
• At beep, add 6 11L RT Master Mix, 1~-tL RNase Inhibitor ( 40,000 U jmL), and 1 11L 
EasyScript Plus™ Reverse Transcriptase (200 U/~-tL) 
• Hit enter to begin reverse transcription 
o 1 minute at 45°C 
o 50 minutes at 52°C 
o 10 minutes at 65°C 
• Holds the temperature at 4°C for storage 
Table 6. Volumes and components needed for reverse transcriptionprotocol. 
3 J.!M Primer RT Master Mix Precipitate Solution 
3 IlL 100 11M Superstock 400 11L RT Buffer 1 11L glycogen 
Water to 100 IlL mark 100 11L 100 mM OTT 2 11L 3M NaOAc (pH- 3.5) 
100 11L 10 mM dNTP mix 50 11L 95% EtOH 
Upon completion of reverse transcription, the solution in each PCR tube was transferred to 
a 1.5 mL centrifuge tube and 53 11L of precipitate solution was added to quench the 
reaction. The tubes were placed on dry icejEtOH for 30 minutes to effectively end the 
reaction. The samples are then recovered using the same recovery procedure as before (pg. 
20), but instead of resuspending the samples in 100 11L water, the samples were stored at-
20°( until the sequencing gel was prepared to be ran. 
RNA Sequencing Gel 
Sequencing gels were used to visualize the cleavage pattern of the RNA following 
ribonuclease digestion with and without ligand bound. Thin ( 41 em), polyacrylamide gels 
were used with 0.35 mm spacers and analyzed using the LI-COR 4300 DNA Analyzer. The 
volumes and components of the gel solution, TBE buffer, and urea dye used can be seen in 
Table 7. 
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Table 7. Volumes and components of the gel solution, TBE buffer, and urea dye used for the 
h. I I 'd I t m, potyacrywm1 e sequencmg ge . 
0.8X TBE Buffer 0.8X Urea Dye Gel Solution 
80 mL lOX TBE 0.36 g urea 14.4 g urea 
Water to 1 L mark 80 IlL lOX TBE 10 mL 40% acrylamide/bisacrylamide 
25 IlL bromophenol blue 3.2 mL lOX TBE 
Water to 1 mL mark Water to 40 mL mark 
320 IlL 10% ammonium persulfate 
32!!L TEMED 
Once the gel polymerized ( ~ 45 minutes), the gel was placed in the DNA Analyzer along 
with 0.8x TBE buffer. The gel was pre-ran for 20 minutes to ensure that any contamination 
was eluted from the gel. The recovered samples were resuspended in 5 11L 0.8X urea dye, 
boiled at 100°C for 5 minutes and centrifuged. The appropriate volume of each sample and 
ladder was loaded into the wells so that there were no spaces in between. The gel was then 
run for 4 hours. 
Results 
ykkCD Riboswitch RNA Synthesis 
After amplifying the ykkCD DNA template using PCR technology and purifying the 
product per suggestion by the manufacturer, the yield was found to be 194.2 ng/11L per 1 
mL of PCR product. The quality of the DNA product was checked using agarose gel 
electrophoresis and a strong band was found around 200 bp, which matches the size of the 
DNA template (Figure 11). The left lane on the gel shows the ladder that was used as a 
standard, and the right lane shows the purified DNA product. The solitary band is indicative 
of a relatively clean product since there are no other bands that suggest any impurities are 
present. 
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Figure 11. Image collected using the Biorad Molecular Imager to analyze the purity of the 
DNA product compared to a standardized ladder on an agarose gel. 
The RNA product was then transcribed using this DNA template and the precipitated RNA 
was purified using gel purification. The yield of the purified RNA was found to be 459.3 
ng/~L per 0.5 mL of the transcription sample. To find the molar concentration, the 
absorbance at 260 nm was divided by the molar extinction coefficient ofykkCD RNA, which 
is 1149800 (Equation 1). The concentration of the RNA was found to be 7.99x10-6 M. 
Absorbance @ 260 nm 9.187 6 Equation 1: . . . . = = 7.99x1o- M RNA 
Molar extmctwn Coefftctent 1149800 
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The purity of the RNA product was checked on a denaturing PAGE. The presence of one 
solid band suggests that the product was pure (Figure 12). 
Figure 12. Image collected using the Biorad Molecular Imager to check the purity of the RNA 
product on a denaturing PAGE gel. 
Optimization of RNA Sequencing Gels 
The optimization of the sequencing gels began with the determination of the 
appropriate amount of sample to load in order to achieve the clearest cleavage pattern. 
When the gel is overloaded with sample, it is difficult to read and analyze the distinct bands 
because the lanes show up as dark streaks (Figure 13). Occasionally, white lines would 
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Figure 13. Representative gels that exhibit overloading in multiple lanes. In the first gel (left), 
the ·majority of the lanes are overloaded. In the second gel (right), the first two lanes are 
overloaded. 
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appear within the solid black streaks, which is another indication of overloading the gel. As 
seen in the gels in Figure 13, when samples are overloaded their cleavage patterns 
disappear and no information can be obtained. In both of these gels, 8 picomoles of the 
sample were loaded in the overloaded lanes. Since this appeared to be too great of an 
amount to load, several gels were ran using different amounts of samples in an attempt to 
optimize the appropriate load. It was found that the optimal amount of sample to load fell 
within the range of 0.6 - 2 picomoles (Figure 14 ). 
Figure 14. The first gel (left) was loaded with 2 picomoles of sample while the second gel 
(right) was loaded with 0.6 picomoles of sample. 
33 
A few of the preliminary gels showed that the sample was being overdigested by the 
enzyme, which made it difficult to read any cleavage patterns. Therefore, approximately 0.3 
11L of tRNA was added to each sample to protect it from over digestion. The nucleases 
cleave both ykkCD RNA and tRNA thus ykkCD RNA will not be cleaved as much. A few 
representative gels (Figure 15) show the difference in the cleavage patterns before and 
after the addition of tRNA. 
.. 
Figure 15. The gel on the left was run before tRNA was introduced into the sample before 
reverse transcription occurred. The gel on the right was run with samples that had tRNA 
added to the master mix prior to reverse transcription. The cleavage pattern is much more 
distinct, which indicates that the sample was not overdigested. 
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The final step of optimization was to determine the enzyme concentration that 
generated the clearest cleavage pattern on the sequencing gel. As shown in Figure 10 in the 
Materials and Methods section, a 1:10 serial dilution was done for each of the enzymes and 
the T1ladder so that it could be determined which enzyme concentration cleaved the 
sample optimally. The same was done for the OH ladder, but instead of a serial dilution, the 
samples were heated at 95°C for 2, 5, and 15 minutes. The enzyme concentrations were 
optimized (Table 8) by visually inspecting cleavage patterns on gels. 
Table 8. Optimized dilutions and concentrations of each sample. 
Sample Dilution Concentration 
OH Ladder - Heated for 5 minutes 
T1 Ladder 2 0.1 UI!!L 
RNase T1 1 1.0 UI!!L 
RNase V1 2 0.01 UI!!L 
RNase 1 3 1.0 UI!!L 
The representative gels for each of the optimizations can be seen in Figures 16-18. In these 
figures, the optimized samples are outlined by a border. The OH ladder generated the 
clearest cleavage pattern when it was heated for 5 minutes (Figure 16). Incubation for 5 
minutes yielded more distinct cleavage patterns than the 2 or 15 minute incubations. 
Similarly, the Tlladder produced the most distinct bands when the enzyme concentration 
was 0.1 Ul 11L. The RNase Tl was optimized at 1.0 Ul 11L (Figure 16), RNase Vi was 
optimized at 0.01 U I 11L (Figure 17), and the RNase 1 was optimized at 1.0 U I 11L (Figure 
18). 
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Figure 16. Optimized samples of the OH ladder, Tlladder, and RNase Tl are outlined in red. 
These dilutions produced the clearest cleavage patterns and were used for all further research. 
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Figure 17. Optimized samples of RNase Vl without and with tetracycline. This dilution was 
used for all further research. 
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Figure 18. Optimized samples of RNase 1 without and with tetracycline. This dilution was 
used for all further research. 
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Detection of Structural Change 
Once the enzyme concentrations and load amounts were optimized, sequencing gels 
were run to detect any structural changes that occurred due to the binding of tetracycline. 
As mentioned earlier, RNase Tl cleaves after every G nucleotide in single-stranded RNA, 
RNase Vl cleaves double-stranded RNA, and RNase 1 cleaves single-stranded RNA. Ideally, 
one would resolve a gel with a clean cleavage pattern for each ladder and each RNase with 
and without tetracycline in order to determine the structural change caused by tetracycline 
binding. Because RNase Tl cleaves after every G nucleot"tle, each band that appears in the 
T1ladder corresponds to a G nucleotide. Therefore, a clean T1ladder can be used to match 
the cleavage pattern caused by a nuclease to the nucleotide sequence of ykkCD. 
To assess structural change, the digested samples are run on the same gel to look for 
areas of protection or enhancement within the cleavage patterns. When protection occurs, 
the sample without tetracycline will be cleaved more heavily than the sample that is bound 
by tetracycline, which will produce darker bands in the cleavage pattern . The lighter band 
in the sample with tetracycline suggests that the binding of tetracycline protected those 
specific nucleotides from being cleaved by the enzyme. When enhancement is detected, the 
opposite has occurred. The lane that contains a sample without tetracycline will have a 
band that is lighter than the corresponding band in the lane that contains the sample with 
tetracycline. The darker band in the sample with tetracycline indicates enhanced cleavage, 
which suggests that the binding of tetracycline caused a structural change that increased 
the vulnerability of those nucleotides to cleavage. Sequencing gels were produced that 
contained evidence of protection (Figures 19 & 20) as well as enhancement (Figures 21 & 
22). 
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Figure 19. Evidence of protection in RNase Tl samples without and with tetracycline. 
In Figure 19 there appears to be protection occurring at several G nucleotides. Both 
of the samples appear to have been loaded equally so any change in the intensity of the 
bands can be contributed to protection or enhancement. It is evident in the sample with 
tetracycline that there is significantly less cleavage occurring, which suggests that either 
tetracycline binds at or near those nucleotides or it binds in such a way that a structural 
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change occurs that protects those specific sites. Other parts of the RNA do not appear to be 
affected by tetracycline binding. The Tlladder is slightly overloaded so it could not be used 
to compare to the RNA sequence to determine which specific G nucleotides in the sequence 
are being protected. 
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Figure 20. Another example of a gel in which there is evidence of protection in RNase Tl 
samples without and with tetracycline. 
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Similar to the previous gel, the Tl samples without and with tetracycline in Figure 
20 exhibit protection in several areas of the sequence. The intensity decreases when 
tetracycline is added, which is once again indicative of a structural change caused by 
binding of tetracycline. The Tlladder in this gel produced a more definite cleavage pattern; 
however, there was a slight amount of waving within the gel that makes interpretation 
difficult. 
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Figure 21. Evidence of enhancement in RNase Vl samples without and with tetracycline. 
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In Figure 21, there is evidence of a slight enhancement within the Vl samples. As 
seen in the enlarged segment, a band appears in the sample with tetracycline that was not 
present in the sample without tetracycline. This indicates that a structural change occurred 
that made those specific nucleotides vulnerable to cleavage by RNase Vl. This enzyme 
specifically cleaves double-stranded RNA. Therefore, this segment of enhancement 
suggests that at that specific point in the RNA sequence the binding of tetracycline caused 
those nucleotides to base pair and become double-stranded instead of single-stranded. 
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Figure 22. Evidence of enhancement in RNase 1 samples without and with tetracycline. 
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RNase 1 specifically cleaves single-stranded RNA. In Figure 22, there are several . 
examples of enhancement that occur when tetracycline is added to the sample. This 
indicates that the binding of tetracycline causes a structural change that separates double-
stranded RNA into single-stranded RNA; thus allowing the single-stranded RNA to be 
cleaved by the enzyme. Unfortunately the ladders that were used on this gel did not 
produce promising cleavage patterns so that exact nucleotides that were being altered 
could not be identified. However, between the gels seen in Figures 21 and 22 it is clear that 
there are structural changes occurring that transform areas of single-stranded RNA into 
double-stranded and double-stranded RNA into single-stranded RNA. 
Because of the ability of both RNase Vl and RN ase 1 to cleave specific areas of a 
sequence, it is highly beneficial to produce a sequencing gel that contains clear cleavage 
patterns for both samples, with and without tetracycline. By comparing cleavage patterns 
produced by these enzymes areas of structural change can be detected because they have 
complementary cleavage patterns. Areas of the RNA that are double-stranded before 
tetracycline is added will show up as distinct bands in the RNase Vl samples but not in the 
RNase 1 samples. In a complementary manner, any areas of single-stranded RNA will not 
show up as bands in the RNase Vl samples, but will appear in the RNase 1 samples. When 
tetracycline is added to the samples, if a conformational change occurs that alters single-
and double-stranded RNA in those areas then the bands that once showed up in the RNase 
Vl sample will now disappear because those nucleotides became single-stranded, thus 
protected from RNase V1. In a corresponding manner, bands will now appear at those same 
locations in the RNase 1 sample that were not present before because the RNA is now 
single-stranded and capable of being cleaved by RNase 1. 
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Figure 23. Comparison of RNase V1 and RNase 1 samples without and with tetracycline. The 
results suggests that tetracycline binding leads to a structural change. 
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As seen in Figure 23, a sequencing gel was produced that contained complementary 
cleavage patterns between RNase V1 and RNase 1. The portion of the gel indicated by 
arrow A shows cleavage of the RNA by RNase V1 which means that those portions of the 
RNA sequence are double-stranded. The lack of bands in the RNase 1 sample supports that 
statement since RNase 1 cannot cleave double-stranded RNA. There is also a slight 
enhancement in the RNase V1 sample with tetracycline, which suggests that RNA becomes 
more structured. 
The portion of the gel indicated by arrow B shows evidence of enhancement in the 
RNase 1 sample when tetracycline is added. The lack of bands in the RNase V1 samples 
suggests that the RNA at that location becomes single-stranded upton tetraycycline binding. 
The pattern then changes at arrow C and distinct bands appear in the RNase V1 samples. 
There also appears to be a slight enhancement within those bands when tetracycline is 
added. The pattern in the RNase 1 samples react complementarily. The faint bands at 
arrow C in the RNase 1 sample without tetracycline disappear when tetracycline binds. 
This suggests that when tetracycline binds to the RNA it is protected from RNase 1 but 
more susceptible to RNase V1, mostly likely because a structural change is occurring that 
transforms any single-stranded RNA in that area to double-stranded RNA. 
Lastly, the portion of the gel that is indicated by arrow D shows both protection in 
the RNase V1 samples and corresponding enhancement in the RNase 1 samples. Although 
the changes in intensity of the bands are slight, the complementary changes in both 
samples when tetracycline is added suggest that another structural change is occurring 
that is separating the double-stranded RNA into single-stranded RNA. Therefore the RNA is 
more susceptible to cleavage by RNase 1 than it is by RNase Vl. 
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Discussion 
Throughout the course of this research project, ykkCD RNA was subjected to 
ribonuclease protection assays followed by reverse transcription to resolve the 
corre~ponding cleavage patterns on a sequencing gel. By observing the changes in the 
cleavage patterns in the presence and absence of tetracycline the goal was to determine 
how the binding of tetracycline altered the secondary structure of the ykkCD RNA. Areas of 
protection and enhancement caused by tetracycline binding can then be compared to the 
nucleotide sequence ofykkCD when nuclease-treated samples and the corresponding 
ladders are resolved clearly on the same gel. 
Ribonuclease protection assays are commonly used and their protocols are well 
established. They are beneficial to use because each RNase has cleaving specificity. Because 
RNase T1 cleaves after every G nucleotide, it helps the researcher orient the cleavage 
pattern within the RNA sequence. More importantly, RNase V1 and RNase 1 work in a 
complementary manner and are sensitive to changes in secondary structure. Because 
RNase V1 cleaves double-stranded RNA and RNase 1 cleaves single-stranded RNA the 
cleavage patterns should change in a synchronized manner if a structural change occurs. 
When these two enzymes are used in conjunction they can offer a lot of information about 
structural changes that are occurring due to metabolite binding. 
During this research project, the assay protocols were optimized for RNase T1, V1, 
and 1 along with the protocols for both ladders. Several sequencing gels were ran with all 
three of the dilutions of each ladder and sample (1U, 0.1U, 0.01U) to determine which 
concentration of each species produced the clearest cleavage patter. The optimized enzyme 
concentrations are summarized in Table 9. 
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Table 9. Optimized enzyme concentrations for each of the nucleases and the optimized 
incubation time for the hydroxyl/adder. 
Sample Concentration 
OH Ladder Heated for 5 minutes 
T1 Ladder 0.1 U/J.!L 
RNase T1 1.0 U/J.!L 
RNase V1 0.01 U/J.!L 
RNase 1 1.0 U/J.!L 
Refer to Figures 16, 17, and 18 for sequencing gels that used the optimized protocols. Once 
each sample was optimized, the focus shifted to producing gels with clean cleavage 
patterns for each sample to begin comparing the patterns in the presence and absence of 
tetracycline. Unfortunately, due to time constraints in the lab it was difficult to produce a 
large volume of gels that contained distinct, readable patterns for every sample. In many 
cases, the RNase samples with and without tetracycline would generate clean cleavage 
patterns but the OH and T1ladders would not be as clear, or the opposite would occur. 
Until both of the ladders can be consistently read on a gel with enough clarity to identify 
each nucleotide, it is not possible to interpret which specific nucleotides in the ykkCD RNA 
sequence are being bound or structurally altered. 
The data collected showed promising evidence of protection and enhancement 
when tetracycline was introduced into the samples. Refer to Figures 19-23 for 
representative gels that exhibit these changes. We were unable to determine which specific 
nucleotides were being protected or enhanced due to the lack of corresponding ladders on 
the same gel, but it is clear that tetracycline binding causes changes to the secondary 
structure in specific areas within the sequence. 
48 
Although each of the enzymes have adequate resolution of their fragmentation 
patterns, RNase V1 and RNase 1 used simultaneously seem to show the most promise and 
the clearest evidence of structural changes since they cleave in a complementary manner. 
Therefore, I think it will be most useful in the future to pursue the study of these two 
ribonucleases in tandem in order to determine how the secondary structure is changing. It 
also may be useful in future research to try other methods of visualizing the fragmentation 
patterns, such as radiolabeling with 32P or trying other fluorescent end-labeling techniques, 
to see if they produce clearer cleavage patterns. However, using the optimized ribonuclease 
protocols determined in this research project, I think it will be possible to identify which 
specific nucleotides in the ykkCD RNA sequence are being affected by tetracycline binding 
using these ribonuclease protection assays. Moreover, I think that it is possible to 
determine the tetracycline binding site on ykkCD RNA in future research using the data 
collected and methods optimized throughout this research project. 
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